Allosteric inhibition of hypoxia inducible factor-2 with small molecules (original) (raw)

• Semenza, G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 33, 207–214 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Xia, X. et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. USA 106, 4260–4265 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Schödel, J. et al. High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq. Blood 117, e207–e217 (2011).
  Article PubMed PubMed Central Google Scholar
• Majmundar, A.J., Wong, W.J. & Simon, M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294–309 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Greer, S.N., Metcalf, J.L., Wang, Y. & Ohh, M. The updated biology of hypoxia-inducible factor. EMBO J. 31, 2448–2460 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Kondo, K., Kim, W.Y., Lechpammer, M. & Kaelin, W.G. Jr. Inhibition of HIF2α is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1, E83 (2003).
  Article PubMed PubMed Central Google Scholar
• Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. & Kaelin, W.G. Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237–246 (2002).
  Article CAS PubMed Google Scholar
• Maranchie, J.K. et al. The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1, 247–255 (2002).
  Article CAS PubMed Google Scholar
• Erbel, P.J., Card, P.B., Karakuzu, O., Bruick, R.K. & Gardner, K.H. Structural basis for PAS domain heterodimerization in the basic helix-loop-helix–PAS transcription factor hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 100, 15504–15509 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, J. et al. Functions of the Per/ARNT/Sim (PAS) domains of the hypoxia inducible factor (HIF). J. Biol. Chem. 280, 36047–36054 (2005).
  Article CAS PubMed Google Scholar
• Partch, C.L., Card, P.B., Amezcua, C.A. & Gardner, K.H. Molecular basis of coiled coil coactivator recruitment by the aryl hydrocarbon receptor nuclear translocator (ARNT). J. Biol. Chem. 284, 15184–15192 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Partch, C.L. & Gardner, K.H. Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B. Proc. Natl. Acad. Sci. USA 108, 7739–7744 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Henry, J.T. & Crosson, S. Ligand-binding PAS domains in a genomic, cellular, and structural context. Annu. Rev. Microbiol. 65, 261–286 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Harper, S.M., Neil, L.C. & Gardner, K.H. Structural basis of a phototropin light switch. Science 301, 1541–1544 (2003).
  Article CAS PubMed Google Scholar
• Wells, J.A. & McClendon, C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001–1009 (2007).
  Article CAS PubMed Google Scholar
• Koehler, A.N. A complex task? Direct modulation of transcription factors with small molecules. Curr. Opin. Chem. Biol. 14, 331–340 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Key, J., Scheuermann, T.H., Anderson, P.C., Daggett, V. & Gardner, K.H. Principles of ligand binding within a completely buried cavity in HIF2α PAS-B. J. Am. Chem. Soc. 131, 17647–17654 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Scheuermann, T.H. et al. Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor. Proc. Natl. Acad. Sci. USA 106, 450–455 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Qing, G. & Simon, M.C. Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypes. Curr. Opin. Genet. Dev. 19, 60–66 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Morris, M.R. et al. Mutation analysis of hypoxia-inducible factors HIF1α and HIF2α in renal cell carcinoma. Anticancer Res. 29, 4337–4343 (2009).
  CAS PubMed Google Scholar
• Kaelin, W.G. Jr. Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein. Cancer 115, 2262–2272 (2009).
  Article CAS PubMed Google Scholar
• Shen, C. et al. Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene. Cancer Discov. 1, 222–235 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Amezcua, C.A., Harper, S.M., Rutter, J. & Gardner, K.H. Structure and interactions of PAS kinase N-terminal PAS domain: model for intramolecular kinase regulation. Structure 10, 1349–1361 (2002).
  Article CAS PubMed Google Scholar
• Rogers, J.L. et al. Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor. J. Med. Chem. 10.1021/jm301847z (30 January 2013).
• Krieg, M. et al. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19, 5435–5443 (2000).
  Article CAS PubMed Google Scholar
• Dioum, E.M. et al. Regulation of hypoxia-inducible factor 2α signaling by the stress-responsive deacetylase sirtuin 1. Science 324, 1289–1293 (2009).
  Article CAS PubMed Google Scholar
• Scortegagna, M. et al. HIF-2α regulates murine hematopoietic development in an erythropoietin-dependent manner. Blood 105, 3133–3140 (2005).
  Article CAS PubMed Google Scholar
• Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721–732 (2003).
  CAS PubMed Google Scholar
• Keith, B., Johnson, R.S. & Simon, M.C. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat. Rev. Cancer 12, 9–22 (2012).
  Article CAS Google Scholar
• Franovic, A., Holterman, C.E., Payette, J. & Lee, S. Human cancers converge at the HIF-2α oncogenic axis. Proc. Natl. Acad. Sci. USA 106, 21306–21311 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Holmquist-Mengelbier, L. et al. Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 10, 413–423 (2006).
  Article CAS PubMed Google Scholar
• Pietras, A. et al. HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc. Natl. Acad. Sci. USA 106, 16805–16810 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Mazumdar, J. et al. HIF-2α deletion promotes Kras-driven lung tumor development. Proc. Natl. Acad. Sci. USA 107, 14182–14187 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ivan, M. et al. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464–468 (2001).
  Article CAS PubMed Google Scholar
• Jaakkola, P. et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468–472 (2001).
  Article CAS PubMed Google Scholar
• Lando, D. et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466–1471 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J. & Whitelaw, M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295, 858–861 (2002).
  Article CAS PubMed Google Scholar
• Kaelin, W.G. Von Hippel-Lindau disease. Annu. Rev. Pathol. 2, 145–173 (2007).
  Article CAS PubMed Google Scholar
• Halavaty, A.S. & Moffat, K. N- and C-terminal flanking regions modulate light-induced signal transduction in the LOV2 domain of the blue light sensor phototropin 1 from Avena sativa. Biochemistry 46, 14001–14009 (2007).
  Article CAS PubMed Google Scholar
• Park, E.J. et al. Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1. Cell Cycle 5, 1847–1853 (2006).
  Article CAS PubMed Google Scholar
• Lee, K. et al. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc. Natl. Acad. Sci. USA 106, 17910–17915 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Semenza, G.L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 20, 51–56 (2010).
  Article CAS PubMed Google Scholar
• Johnson, B.A. & Blevins, R.A. NMRView: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 4, 603–614 (1994).
  Article CAS PubMed Google Scholar
• Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
  Article CAS PubMed Google Scholar
• Adams, P.D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schüttelkopf, A.W. & van Aalten, D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355–1363 (2004).
  Article PubMed Google Scholar
• Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
  PubMed Google Scholar
• Chen, V.B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
  Article CAS PubMed Google Scholar
• Winn, M.D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Martí-Renom, M.A. et al. Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29, 291–325 (2000).
  Article PubMed Google Scholar
• Bookout, A.L. & Mangelsdorf, D.J. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1, e012 (2003).
  Article PubMed PubMed Central Google Scholar
• Scheuermann, T.H., Yang, J., Zhang, L., Gardner, K.H. & Bruick, R.K. Hypoxia-inducible factors Per/ARNT/Sim domains: structure and function. Methods Enzymol. 435, 3–24 (2007).
  CAS PubMed Google Scholar
• Chen, R., Dioum, E.M., Hogg, R.T., Gerard, R.D. & Garcia, J.A. Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner. J. Biol. Chem. 286, 13869–13878 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• McNaney, C.A. et al. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion. Assay Drug Dev. Technol. 6, 121–129 (2008).
  Article CAS PubMed Google Scholar
• Drexler, D.M. et al. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates. Assay Drug Dev. Technol. 5, 247–264 (2007).
  Article CAS PubMed Google Scholar